FCN vs IONS · P/E 23, rev $3.70B vs rev $226.6M
FTI Consulting Inc (FCN) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
FTI Consulting Inc (FCN) is a consulting services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported FCN revenue for 2024-12-31 was $3.70B. Net income was $280.1M. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. FCN currently screens at market cap $5.70B and trailing P/E 22.7.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
FCN currently screens at market cap $5.70B and trailing P/E 22.7. IONS currently screens at market cap $12.28B.
Not investment advice. Open the FCN and IONS stock pages for the full models.
Not investment advice.